// App-Quantinova.ai

: Medication Discontinuation and Survival in Elderly Veterans on Antifibrotics for Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • J. Ryan

Principal Investigators

  • K. Malcolm

  • E. D. Farrand

  • N. A. Kolaitis

  • B. J. Ley

  • J. K. Brown

  • J. R. Greenland

Medical Centers

  • Nursing, Pulmonary and Critical Care Medicine, VA Health Care System, San Francisco, CA, United States,

  • Division of Pulmonary and Critical Care Medicine, University of California, San Diego, La Jolla, United States

  • Nursing, Pulmonary and Critical Care Medicine, VA Health Care System, San Francisco, CA, United States,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Pirfenidone

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A